Bruker Optics offers the industry’s most comprehensive range of solutions based on vibrational spectroscopy for the FDA Process Analytical Technologies (PAT) initiative.

Today's competitive industrial environment requires manufacturers to continuously strive to improve product quality while reducing manufacturing costs. Vibrational spectroscopy, especially near-infrared spectroscopy, is well suited to process analysis, helping achieve these goals.

Bruker Optics is committed to the development and support of leading-edge technology for FT-IR, FT-NIR and Raman spectroscopy systems for both the laboratory and the process environment. The FDA Process Analytical Technologies (PAT) initiative is an effort to facilitate the introduction of new technologies to the manufacturing sectors of the pharmaceutical industry. PAT systems provide timely analysis of critical quality parameters with the end goal of improving final product quality as well as reducing manufacturing costs, thereby significantly benefiting the public health as well as the pharmaceutical industry.